中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity

文献类型:期刊论文

作者Chen, Hua-Dong1,2; Chen, Chuan-Huizi1,2; Wang, Yu-Ting1,2; Guo, Ne1,2; Tian, Yu-Nan1,2; Huan, Xia-Juan1,2; Song, Shan-Shan1,2; He, Jin-Xue1,2; Miao, Ze-Hong1,2,3
刊名INTERNATIONAL JOURNAL OF CANCER
出版日期2019-08-01
卷号145期号:3页码:714-727
关键词PARP1 inhibitor PARP1-DNA binding PARP1-DNA trapping poly(ADP-ribose) polymerase activity cytotoxicity
ISSN号0020-7136
DOI10.1002/ijc.32131
文献子类Article
英文摘要PARP1 inhibitors (PARPis) are used clinically during cancer therapy and are thought to exert their cytotoxicity through PARP1 polymerase inhibition and PARP1-DNA trapping. Here, we showed no significant correlation between PARP1-DNA trapping and cytotoxicity induced by PARPis. We complemented PARP1-knockout sublines with wild-type PARP1 and 11 mutants with different point mutations that affect the polymerase activity. When examining the PARPi talazoparib, the induced cytotoxicity was highly significantly correlated with cellular PARP1 polymerase activity, but not with its PARP1-DNA trapping or polymerase inhibition. Similarly, talazoparib's PARP1-DNA trapping revealed significant correlation with the polymerase activity rather than its inhibition. Differently, however, when evaluating purified wild-type and mutated PARP1, we identified an almost linear relationship between PARPis' inhibiting PARP1 dissociation from DNA and their cytotoxicity in 17 cancer cell lines. In contrast, no significant correlation existed between PARP1 polymerase inhibition in the histone-based systems and the cytotoxicity. After careful comparisons on different methods and detection targets, we conclude that the PARPi-mediated increase in PARP1-DNA binding by inhibiting autoPARylation of PARP1 on DNA rather than in PARP1-DNA trapping is correlated with PARPi's cytotoxicity. Accordingly, we established a new PARPi screening model that more closely predicts cytotoxicity.
WOS关键词POLY(ADP-RIBOSE) POLYMERASE ; ANTICANCER ACTIVITY ; STRUCTURAL BASIS ; HIGHLY POTENT ; BMN 673 ; DISCOVERY ; DESIGN ; OPPORTUNITIES ; MECHANISM ; EFFICACY
WOS研究方向Oncology
语种英语
WOS记录号WOS:000470911700015
出版者WILEY
源URL[http://119.78.100.183/handle/2S10ELR8/309424]  
专题新药研究国家重点实验室
通讯作者Miao, Ze-Hong
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
2.Univ Chinese Acad Sci, Beijing, Peoples R China;
3.Pilot Natl Lab Marine Sci & Technol Qingdao, Open Studio Druggabil Res Marine Nat Prod, Qingdao, Shandong, Peoples R China
推荐引用方式
GB/T 7714
Chen, Hua-Dong,Chen, Chuan-Huizi,Wang, Yu-Ting,et al. Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity[J]. INTERNATIONAL JOURNAL OF CANCER,2019,145(3):714-727.
APA Chen, Hua-Dong.,Chen, Chuan-Huizi.,Wang, Yu-Ting.,Guo, Ne.,Tian, Yu-Nan.,...&Miao, Ze-Hong.(2019).Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.INTERNATIONAL JOURNAL OF CANCER,145(3),714-727.
MLA Chen, Hua-Dong,et al."Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity".INTERNATIONAL JOURNAL OF CANCER 145.3(2019):714-727.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。